Zyne stock forecast

Real-time trade and investing ideas on Zynerba Pharmaceuticals ZYNE from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. ZYNE | Zynerba Pharmaceuticals Inc. Stock Price & News - WSJ View the latest Zynerba Pharmaceuticals Inc. (ZYNE) stock price, news, historical charts, analyst ratings and financial information from WSJ.

ZNGA - Zynga Inc Stock quote - CNNMoney.com Find real-time ZNGA - Zynga Inc stock quotes, company profile, news and forecasts from CNN Business. Find real-time ZNGA - Zynga Inc stock quotes, company profile, news and forecasts from CNN Zynerba Pharmaceuticals, Inc. (ZYNE) Stock Price, Quote ... Find the latest Zynerba Pharmaceuticals, Inc. (ZYNE) stock quote, history, news and other vital information to help you with your stock trading and investing.

Ahead of Wall Street - Daily Stock Market Outlook

Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Zynerba Pharmaceuticals Inc have a median target of 16.00, with a high estimate of  Stock Price Forecast for ZYNE: Zynerba Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still  Exploring Zynerba Pharmaceuticals (NASDAQ:ZYNE) stock? View ZYNE's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC  Zynerba Pharmaceuticals Stock Price Forecast, ZYNE stock price prediction. The best long-term & short-term Zynerba Pharmaceuticals share price prognosis for  Zynerba Pharmaceuticals (ZYNE) stock price prediction is 3.032 USD. The Zynerba Pharmaceuticals stock forecast is 3.032 USD for 2021 April 07, Wednesday;  Based on 4 analysts offering 12 month price targets for Zynerba Pharmaceuticals in the last 3 months. The average price target is $20.75 with a high forecast of 

Forecast Cash Runway: ZYNE has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of -32.8% each year. Next Steps Explore more healthy companies in the Pharmaceuticals & Biotech industry.

Zynerba Pharmaceuticals stock forecast, ZYNE price ...

ZYNE - Zynerba Pharma CS Stock Price - Barchart.com

Zynerba Pharmaceuticals, Inc Stock Price Forecast, "ZYNE" Predictons for2020 Zynerba Pharmaceuticals, Inc. (ZYNE) Analyst Ratings ... See Zynerba Pharmaceuticals, Inc. (ZYNE) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Zynerba Pharmaceuticals Stock Forecast | ZYNE Stock ... See ZYNE stock predictions by 5 financial experts and find out if their Zynerba Pharmaceuticals stock forecast (ZYNE) is more bullish in comparison to other stocks in the Healthcare sector. Our Zynerba Pharmaceuticals Stock Prediction in 2019 (Buy ...

ZYNE | Stock Snapshot - Fidelity

23 Mar 2020 Needham advised investors in its research note published on October 21, 2019, to Buy the ZYNE stock while also putting a $18 price target. Stock Forecast Based On a Predictive Algorithm | I Know First | 23 Sep 2019 news market updates,stocks,stonks,market today,stock market,stock stock, zynerba pharmaceuticals,zyne,zyne stock,aurora stock,indiva stock  Stock Forecast can refer to: Stock forecasts based on human experience: Human traders based on their experience in terms of stock price patterns, volume  Inventory forecasting models such as determining reorder points (ROP) and economic order quantities can help ensure optimal inventory control. stock valuation, newsletter, stock report, institutional software, financial reports, stock Find a fair value for your stocks and forecast their future prospects. ZYNE - Zynerba Pharmaceuticals Inc Stock quote - CNNMoney.com

Zynerba Pharmaceuticals (ZYNE) Stock Message Board ... Apr 02, 2020 · Zynerba Pharmaceuticals, Inc., (Nasdaq: ZYNE) announced today the pricing of its initial public offering of 3 million shares of common stock at a public offering price of $14.00 per share, before underwriting discounts. All of the shares in the offering are being sold by Zynerba. ZYNE - Zynerba Pharma CS Stock Price - Barchart.com 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. ZYNE - Zynerba Pharma CS Stock Price History - Barchart.com